In rat hearts, the presence of guanine nucleotides removes the high-sensitivity form of adrenaline receptors, leaving only the low-sensitivity form—this mechanism still works even when thyroid hormone levels are high.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review could determine whether guanine nucleotides universally abolish high-affinity agonist binding across species and receptor subtypes, including under thyroid hormone modulation.
A systematic review and meta-analysis of all studies measuring agonist binding in cardiac membranes with and without GTP or its analogs, stratified by thyroid status, species, and receptor subtype, using standardized protocols.
An RCT could determine whether thyroid hormone exposure alters the sensitivity of receptor-G-protein coupling to guanine nucleotides.
A double-blind trial in 48 rats randomized to receive T3 (10 µg/kg/day) or vehicle for 14 days, followed by cardiac membrane preparation with and without GTPγS, measuring high-affinity binding fraction as primary endpoint.
A cohort study could determine whether changes in G-protein coupling efficiency correlate with thyroid hormone levels over time in humans.
A prospective cohort study following 60 patients with Graves' disease for 12 months, measuring G-protein coupling efficiency via GTPγS shift in endomyocardial biopsies and correlating with serum T3 levels.
A case-control study could compare G-protein coupling efficiency in cardiac tissue from hyperthyroid versus euthyroid patients.
A case-control study comparing GTPγS-induced shift in isoproterenol binding affinity in cardiac membranes from 25 hyperthyroid and 25 euthyroid patients, matched for age, sex, and cardiac pathology.
A cross-sectional study could correlate serum thyroid hormone levels with G-protein coupling efficiency in living humans via surrogate measures.
A cross-sectional study measuring serum T3/T4 and G-protein coupling efficiency via PET imaging with a GTP-sensitive beta-agonist tracer in 120 adults with varying thyroid function.